ChiCTR2000037864 版本V1.0 版本创建时间2020/10/10 22:49:43 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000037864 

最近更新日期:

Date of Last Refreshed on:

2020-09-03 01:51:17 

注册时间:

Date of Registration:

2020-09-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

请与我们联系上传伦理批件 比较可回收金属支架与内镜下扩张术治疗食管癌术后吻合口良性狭窄的前瞻性、多中心、随机对照研究

Public title:

A prospective, multicentre, randomized controlled study comparing recyclable metal stents with endoscopic dilatation for benign anastomotic stenosis after esophagectomy for esophageal cancer

注册题目简写:

English Acronym:

研究课题的正式科学名称:

比较可回收金属支架与内镜下扩张术治疗食管癌术后吻合口良性狭窄的前瞻性、多中心、随机对照研究

Scientific title:

A prospective, multicentre, randomized controlled study comparing recyclable metal stents with endoscopic dilatation for benign anastomotic stenosis after esophagectomy for esophageal cancer

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

蒲文凤 

研究负责人:

张涛 

Applicant:

pu wenfeng 

Study leader:

zhang tao 

申请注册联系人电话:

Applicant telephone:

15181771177

研究负责人电话:

Study leader's telephone:

15810313927

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1047951869@qq.com

研究负责人电子邮件:

Study leader's E-mail:

305514271@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省南充市中心医院

研究负责人通讯地址:

四川省南充市中心医院

Applicant address:

Nanchong Central Hospital, Sichuan Province

Study leader's address:

Nanchong Central Hospital, Sichuan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南充市中心医院

Applicant's institution:

南充市中心医院

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019080

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

南充市中心医院伦理委员会

Name of the ethic committee:

Ethics Committee of Nanchong Central Hospita

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

覃蓉

Contact Name of the ethic committee:

qinrong

伦理委员会联系地址:

四川省南充市中心医院

Contact Address of the ethic committee:

Nanchong Central Hospital, Sichuan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南充市中心医院

Primary sponsor:

Nanchong Central Hospital

研究实施负责(组长)单位地址:

四川省南充市中心医院

Primary sponsor's address:

Nanchong Central Hospital, Sichuan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川

市(区县):

南充

Country:

China

Province:

Sichuan

City:

Nanchong

单位(医院):

南充市中心医院

具体地址:

顺庆区人民南路97号

Institution
hospital:

Nanchong Central Hospital

Address:

97 Renmin Road South, Shunqing District

经费或物资来源:

科研经费

Source(s) of funding:

funding

Target disease:

Postoperative esophageal cancer

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

通过比较可回收金属支架与内镜下扩张术对食管癌术后吻合口良性狭窄的作用,探讨内镜下治疗食管癌术后吻合口良性狭窄的最佳治疗方式。  

Objectives of Study:

By comparing the effects of recyclable metal scaffolds and endoscopic dilatation on benign anastomotic stenosis after esophagectomy, the optimal treatment method for benign anastomotic stenosis after esophagectomy was explored

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

① 年龄在18-75岁之间;② 食管癌食管切除患者;③ 有吞咽梗阻症状;④ 食管钡餐或造影显示吻合口狭窄;⑤ 胃镜下吻合口未见新生物,镜身不能通过吻合口;⑥ 签署知情同意书。

Inclusion criteria

1.Between 18 and 75 years old;2. Patients with esophagectomy for esophageal cancer;3. Symptoms of swallowing obstruction; 4. Esophageal barium meal or radiography showed anastomotic stenosis; 5.No new organisms were found in the anastomosis under gastroscopy, and the endoscopic surface could not pass through the anastomosis; 6.Sign informed consent.

排除标准:

① 吻合口瘘患者;② 身体状态差,不能耐受胃镜检查者;③ 吻合口食管癌复发患者;④ 不愿参加本试验者;⑤ 有严重心肺疾患、凝血功能障碍、严重贫血和其他器官肿瘤性疾病,影响胃镜下扩张或支架置入操作或术后随访者;⑥ 曾行内镜下扩张术或支架置入术治疗吻合口狭窄者。

Exclusion criteria:

1.Patients with anastomotic fistula;2. Poor physical condition, unable to tolerate gastroscopy;3. Patients with anastomotic esophageal cancer recurrence; 4. those who do not want to participate in the experiment;5. Patients with severe cardiopulmonary diseases, coagulation disorders, severe anemia and other organ-neoplastic diseases, affecting gastroscope expansion or stent implantation or postoperative follow-up; 6.Patients who have undergone endoscopic dilatation or stent implantation for anastomotic stenosis

研究实施时间:

Study execute time:

From 2020-10-10 00:00:00 To 2022-10-10 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-09-30 00:00:00 To 2022-10-10 00:00:00  

干预措施:

Interventions:

组别:

Group 1

样本量:

100

Group:

Group 1

Sample size:

干预措施:

内镜下扩张

干预措施代码:

Intervention:

Endoscopic dilatation

Intervention code:

组别:

Group 2

样本量:

100

Group:

Group 2

Sample size:

干预措施:

内镜下可回收金属支架置入

干预措施代码:

Intervention:

Endoscopically retrievable metal stent placement

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

南充 

Country:

China 

Province:

Sichuan 

City:

Nanchong 

单位(医院):

南充市中心医院 

单位级别:

三级甲等 

Institution
hospital:

Nanchong Central Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

症状

指标类型:

主要指标

Outcome:

symptom

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

食管钡餐或造影检查

指标类型:

主要指标

Outcome:

Esophageal barium meal or radiography examination

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胃镜检查

指标类型:

主要指标

Outcome:

gastroscopy

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

扩张或支架置入次数

指标类型:

主要指标

Outcome:

Times of dilation or stent placement

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后卫生经济评估

指标类型:

主要指标

Outcome:

Postoperative health economics assessment

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者生存质量评估

指标类型:

主要指标

Outcome:

Patient quality of life assessment

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用随机数字表法实现随机化。

Randomization Procedure (please state who generates the random number sequence and by what method):

The random number table method is adopted to realize the randomization

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后6个月内公开,上传至平台

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The test will be published within 6 months after completion and uploaded to the platform

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

制作病例记录表,后期统计数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Make case records and later statistical data

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-09-03 01:51:17